Medicine and Dentistry
Chimeric Antigen Receptor
100%
Co-Stimulation
66%
Chimeric Antigen Receptor T-Cell Immunotherapy
50%
Pre-Clinical Development
50%
Transplantation
50%
Cell Therapy
50%
Clinical Trial
50%
Ex Vivo
50%
T-Cell Signaling
50%
T Cell
44%
Antineoplastic Activity
38%
Therapeutics
33%
Adoptive Transfer
33%
Chimeric Antigen Receptor T-Cell
30%
Receptor
28%
Stimulation
18%
Patient Population
16%
Patient
16%
B Cell
16%
Toxicity
16%
Disease
16%
Cancer
16%
Transplantation Tolerance
16%
Insulin Dependent Diabetes Mellitus
16%
Cells
16%
Bone Marrow Transplantation
16%
Culture
16%
Immunoregulation
16%
Phase I Trials
16%
Human T Regulatory Cell
16%
Solid Organ Transplantation
16%
Genome Editing
16%
Chemotherapy
16%
Aptitude
10%
Xenograft
10%
Marker
10%
Combination Therapy
10%
Target Cell
10%
Single Chain Fragment Variable Antibody
10%
Tumor Cell
10%
Alanine
10%
Artificial Receptor
8%
Neoplasm
8%
Hematologic Malignancy
8%
Cytokine Release
8%
Fitness
8%
Immune Response
8%
Cytokine Signaling
8%
Senescence
8%
Biochemistry, Genetics and Molecular Biology
Membrane
50%
Signal Transduction
50%
Avidity
50%
Cancer Cell
33%
Solid
33%
Integrin
16%
Prostaglandin E2 Receptor
16%
